Meghan Trainor has opened up about sharing her weight loss journey with her husband Daryl Sabara. On a recent episode of her Workin’ On It podcast with her brother Ryan, the singer revealed that both she and Sabara are currently using Mounjaro, a diabetes medication increasingly being used to support weight loss.
After welcoming their son Riley, the couple initially took on the 75 Hard challenge. A demanding lifestyle program, and saw encouraging results. But as they learned more about weight loss medications like Mounjaro and Ozempic from friends and medical professionals, they became curious. Trainor eventually opted for Mounjaro after researching its effects and concluding that it appeared to cause fewer side effects than similar drugs.
Though she has lost weight through diet and exercise in the past, Trainor explained that she consulted with her doctor and decided she felt safe using the medication. Sabara soon joined her, saying that they tend to approach most things in life as a team. He also shared that he had gained weight during Trainor’s pregnancies and wanted to take a healthier approach to shedding it.
Health, Fitness, and Scientific Backing Of Meghan Trainor’s Plan
The couple emphasized that they are on the lowest available dose of Mounjaro and remain committed to exercise and healthy eating. Their focus has been on preserving muscle mass and staying active, rather than relying solely on medication to achieve their goals. They noted that one major change they noticed was a reduced appetite, which helped them maintain discipline in their routines.
This isn’t the first time Trainor has addressed her evolving body. At the 2025 Billboard Women in Music Awards, where she received the Hitmaker Award, she posted photos on Instagram and addressed criticism about her appearance. She expressed frustration that the focus was on her body rather than her musical achievements and reflected on her personal journey toward becoming healthier and stronger for herself and her family.
Meghan Trainor worked closely with a dietitian, made lifestyle changes, and began working out with a trainer. She emphasized that science supported her post-pregnancy recovery but was just one part of a broader wellness approach.
Scientific data backs Mounjaro’s effectiveness. A trial with 750 obese participants showed that after 72 weeks, those on Mounjaro lost 20% of their body weight, outperforming Wegovy’s 14% reduction. Mounjaro also reduced waist circumference and improved metabolic health, including blood pressure and cholesterol.
Both medications target the brain’s appetite centers, but Mounjaro affects two receptors, possibly explaining its higher effectiveness. Women in the study generally lost more weight than men.
For Trainor and Sabara, the focus is on overall health, teamwork, and making informed, sustainable decisions.
